Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 17, 2026

Labeling Stem Cells with Ferumoxytol, an FDA-Approved Iron Oxide Nanoparticle
05:05

Labeling Stem Cells with Ferumoxytol, an FDA-Approved Iron Oxide Nanoparticle

Published on: November 4, 2011

Imaging circulating cells and lymphoid tissues with iron oxide nanoparticles.

Andrew Elias1, Andrew Tsourkas

  • 1Department of Bioengineering, University of Pennsylvania, Philadelphia, PA 19104, USA. raelias@seas.upenn.edu

Hematology. American Society of Hematology. Education Program
|December 17, 2009
PubMed
Summary

Iron oxide nanoparticles are promising magnetic resonance contrast agents for imaging circulating cells and lymphoid tissues. Their high detectability, biodegradability, and low toxicity offer significant advantages in disease diagnosis and monitoring.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antibody Conjugation Strategies for Ultrasound Microbubbles: A Review of Bioconjugation Chemistry and Clinical Translation.

Ultrasound in medicine & biology·2026
Same author

Resolving heterogeneity of targeted lipid nanoparticles through solution-based biophysical analyses.

bioRxiv : the preprint server for biology·2026
Same author

Micelle-Encapsulated Theranostic Phthalocyanine and Naphthalocyanine Derivatives for Photothermal Therapy and Photoacoustic Imaging with NIR-I vs NIR-II Irradiation.

ACS applied nano materials·2026
Same author

PLGA nanoparticles restore acidic pH and degradative function to compromised lysosomes with Cy3-labeling providing enhanced tracking to lysosomes.

American journal of physiology. Cell physiology·2026
Same author

In vivo imaging of reactive oxygen species after myocardial ischemia-reperfusion injury: a large animal multimodal imaging and transcriptomic study.

bioRxiv : the preprint server for biology·2025
Same author

Varespladib-Based Lipid Nanoparticles as Highly Efficient Anti-Inflammatory Agents for Osteoarthritis Treatment.

ACS applied materials & interfaces·2025

Area of Science:

  • Biomedical Imaging
  • Nanotechnology
  • Medical Diagnostics

Background:

  • Iron oxide nanoparticles (IONPs) and particles are increasingly studied as magnetic resonance (MR) contrast agents.
  • Applications span cell tracking, molecular imaging, gene detection, and lymphography in biology and medicine.
  • IONPs offer high MR detectability, biodegradability, and low toxicity, making them attractive for medical use.

Purpose of the Study:

  • To describe recent advancements in using magnetic nanoparticles for imaging circulating cells and lymphoid tissues.
  • To highlight the importance of studying the lymphatic system and immune cell biodistribution.
  • To underscore the potential impact on disease diagnosis, prognosis, and treatment.

Main Methods:

  • Utilizing nanometer-sized and micron-sized iron oxide particles.

More Related Videos

Cell Labeling and Targeting with Superparamagnetic Iron Oxide Nanoparticles
08:26

Cell Labeling and Targeting with Superparamagnetic Iron Oxide Nanoparticles

Published on: October 19, 2015

Labeling hESCs and hMSCs with Iron Oxide Nanoparticles for Non-Invasive in vivo Tracking with MR Imaging
09:06

Labeling hESCs and hMSCs with Iron Oxide Nanoparticles for Non-Invasive in vivo Tracking with MR Imaging

Published on: March 31, 2008

Related Experiment Videos

Last Updated: Jun 17, 2026

Labeling Stem Cells with Ferumoxytol, an FDA-Approved Iron Oxide Nanoparticle
05:05

Labeling Stem Cells with Ferumoxytol, an FDA-Approved Iron Oxide Nanoparticle

Published on: November 4, 2011

Cell Labeling and Targeting with Superparamagnetic Iron Oxide Nanoparticles
08:26

Cell Labeling and Targeting with Superparamagnetic Iron Oxide Nanoparticles

Published on: October 19, 2015

Labeling hESCs and hMSCs with Iron Oxide Nanoparticles for Non-Invasive in vivo Tracking with MR Imaging
09:06

Labeling hESCs and hMSCs with Iron Oxide Nanoparticles for Non-Invasive in vivo Tracking with MR Imaging

Published on: March 31, 2008

  • Employing magnetic resonance imaging techniques.
  • Focusing on applications in cell tracking and lymphography.

    • Main Results:

    • Demonstrated progress in the application of magnetic nanoparticles for imaging.
    • Highlighted the utility of iron oxide in visualizing circulating cells and lymphoid tissues.
    • Showcased favorable properties of iron oxide, including high MR detectability and low toxicity.

    Conclusions:

    • Magnetic nanoparticles, particularly iron oxide, show significant potential in advanced biomedical imaging.
    • Imaging circulating cells and lymphoid tissues using these agents can provide crucial insights into disease.
    • Further development is expected to enhance diagnostic and therapeutic strategies, improving patient outcomes.